Navigation Links
NeurogesX Closes $25 Million Private Placement
Date:1/9/2008

rials with NGX- 4010 have been completed and have met their primary endpoints, two in PHN and one in painful HIV-DSP.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to the expected benefits of NeurogesX' potential products, including its lead product candidate NGX-4010. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, past results of clinical trials may not be indicative of future clinical trials results; NeurogesX' product candidate may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; physician or patient reluctance to use NGX-4010, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in clinical development, obtaining regulatory approval, market acceptance and commercialization of NGX-4010. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX

Stephen Ghiglieri

(650) 358-3310

sghiglieri@neurogesx.com

The Ruth Group

Investors / Media

Stephanie Carrington / Jason Rando

(646) 536-7017 / 702
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeurogesX, Inc. Announces $25 Million Private Placement
2. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
3. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
6. NeurogesX Appoints New Director to the Board
7. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
8. AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock
9. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
10. Helix BioPharma closes $16.9 million private placement of common shares
11. The closest look ever at native human tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... DIEGO, Nov. 21 Gen-Prob...ay may be an important new molecular tool to more,...(HPV) infections that are,associated with cervica...e,oral presentations and two scientific posters p...esearchers at the international conference of the,...
(Date:11/20/2008)...DCLIFF LAKE, N.J., Nov. 20 /PRNewswire-FirstCall/ ... ) today announced that the U.S. District Court fo...traZeneca Pharmaceuticals, motion for a temporary ...neric Pulmicort Respules(R) (budesonide inhaled so...ainst Teva, AstraZeneca agreed and that it too wou...
(Date:11/20/2008)...FORD, Mass., Nov. 20 Hol..., manufacturer and supplier of premium,diagnostic...edicated to,serving the healthcare needs of women... for members of the investment community who will ...rth America) trade show in Chicago. , This ...
(Date:11/20/2008)... International Agreement Licenses Seno,s Opto-Ac...Enable Molecular Imaging at the Cellular Level and...e Medicine, Inflammation, and, Cancer Applicat.... 20 /PRNewswire/ - VisualSonics and Seno Medical ...f a licensing agreement providing VisualSonics exc...
Breaking Biology Technology:Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research 2VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research 3
... provider of weather graphics systems and related ...he media division of Meteorlogix , based in Burns...ducts including the new X television weather grap...d nearly a dozen other products and services are ...pened a division office in Eagan, Minn., and all k...
... requires careful attention not just to infrastruc...according to Debbie Christofferson, president of ...r door, and do you have it open a crack, or are al...ednesday at the ITEC conference in Milwaukee . , ...rity is enough?, she said many of the security pro...
...om a new orbiting infrared telescope are revealing...eneral - is making new stars at a much more prolif... from NASA,s Spitzer Space Telescope were announce...fing by Edward Churchwell, a University of Wiscons...ducting the most detailed survey to date of our ga...
...reated with Sonic Foundry s Mediasite have a ho...ch help organizations capture presentations digita... hosted service platform created exclusively for M...leased in tandem Friday. , ,Now customers of any ... communications without the up-front expense and t...
Other Biology Technology:Expert says network security is about people, not just computers 2Milky Way churning out new stars at a furious pace 2Milky Way churning out new stars at a furious pace 3BxVideo designs Web hosting service for Sonic Foundry media presentations 2
(Date:11/20/2008)...cal Systems Inc., (NMS), an Austin-based startup c...y of Texas Health Science Center at Houston (UTHSC...ncer agents and other medications, has received a ...h the Texas Emerging Technology Fund (ETF). , NM...wards, which were announced by Texas Gov. Rick Per...
(Date:11/20/2008)...lease is available in German . , Halle/Saa... comprehensive overview of which alien species are... for the environment and society. More than 11,000...ivering Alien Invasive Species Inventory for Europ... than 100 European scientists, funded by the Europ...
(Date:11/20/2008)...ennia, people have grown soybeans and turned them ...derstanding why a soybean grows, blooms or produce...ed questions. , University of Georgia professor...ee-year, $2.5 million grant from the National Scie... a UGA colleague. , "I,m convinced that soybeans...
(Date:11/20/2008)... virtual crime, treating an ageing population, and...l be the focus of a 20 million ($30.4 million) inv...sical Sciences Research Council (EPSRC), Technolog...iological Sciences Research Council (BBSRC). , T...areas where world-class scientific breakthroughs h...
Breaking Biology News(10 mins):Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari 211,000 alien species invade Europe 2Soybean grant gives researchers tools to unravel better bean 2£20 million to fight virtual crime and treat our aging population 2£20 million to fight virtual crime and treat our aging population 3Bedside Manner Board Certification Matter 3A Survey Reveals Top Qualities for Consumers Choosing a Doctor 24976 1Bedside Manner Board Certification Matter 3A Survey Reveals Top Qualities for Consumers Choosing a Doctor 24976 2Bedside Manner Board Certification Matter 3A Survey Reveals Top Qualities for Consumers Choosing a Doctor 24976 3Bedside Manner Board Certification Matter 3A Survey Reveals Top Qualities for Consumers Choosing a Doctor 24976 4MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11 2008 6924 1MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11 2008 6924 2Vitamin C injections slow tumor growth in mice 24969 1Vitamin C injections slow tumor growth in mice 24969 2Vitamin C injections slow tumor growth in mice 24969 3Blood Thinner Plavix Works Harder in Smokers 24966 1Blood Thinner Plavix Works Harder in Smokers 24966 2
...e immune system police, learn early in life what t...and tumors, researchers have shown. , Using genet...s a snapshot of the repertoire of antigen receptor...lege of Georgia researchers followed T cells as th.... , They found regulatory T cells learn what to ...
...ales of many species face, and some may go to extr...e June issue of the American Naturalist, Darren Cr... the University of Leeds suggest that female guppi...to avoid too much attention from males. Observing ...inidad, the researchers found that female guppies ...
...re and the fossil record abound with examples of s...in a variety of animals. But scientists have debat...l evolution also can be found at the level of gene...ature Genetics June 11, evolutionary biologist Jia... instance in a gene for an enzyme that helps leaf-...
...European Journal of Nutrition demonstrates a stron...ese postmenopausal women and the dose-dependent ef...®. These findings support previous scientific find... women. , According to the authors of the study, "...about one in three postmenopausal women, with estr...
Other Biology News:Immune system police learn early and sometimes badly 2Immune system police learn early and sometimes badly 3Parallel evolution: Proteins do it, too 2Parallel evolution: Proteins do it, too 3New research: Soy germ isoflavones reduce bone loss 2